American Journal of Ophthalmology
Volume 139, Issue 3 , Pages 476-481 , March 2005

Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy

  • Daisuke Watanabe, MD, PhD

      Affiliations

    • Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan.
    • ,
  • Kiyoshi Suzuma, MD, PhD

      Affiliations

    • Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan.
    • ,
  • Izumi Suzuma, MD, PhD

      Affiliations

    • Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan.
    • ,
  • Hirokazu Ohashi, MD, PhD

      Affiliations

    • Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan.
    • ,
  • Tomonari Ojima, MD

      Affiliations

    • Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan.
    • ,
  • Masafumi Kurimoto, MD

      Affiliations

    • Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan.
    • ,
  • Tomoaki Murakami, MD

      Affiliations

    • Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan.
    • ,
  • Tetsushi Kimura, MD

      Affiliations

    • Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan.
    • ,
  • Hitoshi Takagi, MD, PhD

      Affiliations

    • Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan.
    • Corresponding Author InformationInquiries to Hitoshi Takagi, MD, PhD, Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, 54 Shogoinkawara-cho, Sakyo-ku, Kyoto 606-8507, Japan; fax: (+81) 75-752-0933

,Accepted 4 October 2004.

References 

  1. Moss SE , Klein R , Klein BE . The 14-year incidence of visual loss in a diabetic population . Ophthalmology . 1998;105:998–1003
  2. Early Treatment Diabetic Retinopathy Study Research Group Fong DS , Ferris FL , Davis MD , Chew EY . Causes of severe visual loss in the early treatment diabetic retinopathy study (ETDRS report no. 24) . Am J Ophthalmol . 1999;127:137–141
  3. Aiello LP , Avery RL , Arrigg PG , et al.   Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders . N Engl J Med . 1994;331:1480–1487
  4. Adamis AP , Miller JW , Bernal MT , et al.   Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy . Am J Ophthalmol . 1994;118:445–450
  5. Burgos R , Simo R , Audi L , et al.   Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy . Diabetologia . 1997;40:1107–1109
  6. Ogata N , Nishikawa M , Nishimura T , et al.   Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy . Am J Ophthalmol . 2002;134:348–353
  7. Funatsu H , Yamashita H , Nakanishi Y , Hori S . Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy . Br J Ophthalmol . 2002;86:311–315
  8. Simo R , Lecube A , Segura RM , et al.   Free insulin growth factor-I and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy . Am J Ophthalmol . 2002;134:376–382
  9. Noma H , Funatsu H , Yamashita H , et al.   Regulation of angiogenesis in diabetic retinopathy (possible balance between vascular endothelial growth factor and endostatin) . Arch Ophthalmol . 2002;120:1075–1080
  10. Suri C , Jones PF , Patan S , et al.   Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis . Cell . 1996;87:1171–1180
  11. Kwak HJ , So JN , Lee SJ , et al.   Angiopoietin-1 is an apoptosis survival factor for endothelial cells . FEBS Lett . 1999;448:249–253
  12. Papapetropoulos A , Garcia-Cardena G , Dengler TJ , et al.   Direct actions of angiopoietin-1 on human endothelium (evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors) . Lab Invest . 1999;79:213–223
  13. Maisonpierre PC , Suri C , Jones PF , et al.   Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis . Science . 1997;277:55–60
  14. Holash J , Maisonpierre PC , Compton D , et al.   Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF . Science . 1999;284:1994–1998
  15. Asahara T , Chen D , Takahashi T , et al.   Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization . Circ Res . 1998;83:233–240
  16. Mandriota SJ , Pepper MS . Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia . Circ Res . 1998;83:852–859
  17. Oh H , Takagi H , Suzuma K , et al.   Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells . J Biol Chem . 1999;274:15732–15739
  18. Stratmann A , Risau W , Plate KH . Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis . Am J Pathol . 1998;153:1459–1466
  19. Hackett SF , Ozaki H , Strauss RW , et al.   Angiopoietin 2 expression in the retina (upregulation during physiologic and pathologic neovascularization) . J Cell Physiol . 2000;184:275–284
  20. Otani A , Takagi H , Oh H , et al.   Expressions of angiopoietins and Tie2 in human choroidal neovascular membranes . Invest Ophthalmol Vis Sci . 1999;40:1912–1920
  21. Takagi H , Koyama S , Seike H , et al.   Potential role of the angiopoietin/tie2 system in ischemia-induced retinal neovascularization . Invest Ophthalmol Vis Sci . 2003;44:393–402
  22. Aiello LP , Pierce EA , Foley ED , et al.   Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins . Proc Natl Acad Sci U S A . 1995;92:10457–10461
  23. Miller JW , Adamis AP , Shima DT , et al.   Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model . Am J Pathol . 1994;145:574–584
  24. Pierce EA , Avery RL , Foley ED , et al.   Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization . Proc Natl Acad Sci U S A . 1995;92:905–909
  25. Stratmann A , Risau W , Plate KH . Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis . Am J Pathol . 1998;153:1459–1466
  26. Malecaze F , Clamens S , Simorre-Pinatel V , et al.   Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy . Arch Ophthalmol . 1994;112:1476–1482

 This study was supported by grants-in-aid for scientific research from the Ministry of Education, Science, and Culture and the Ministry of Health and Welfare of the Japanese Government (15390529 and 14704045).

PII: S0002-9394(04)01239-5

doi: 10.1016/j.ajo.2004.10.004

American Journal of Ophthalmology
Volume 139, Issue 3 , Pages 476-481 , March 2005

Article Tools

* Image Usage & Resolution